The Returns At Shandong Pharmaceutical GlassLtd (SHSE:600529) Aren't Growing

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. With that in mind, the ROCE of Shandong Pharmaceutical GlassLtd (SHSE:600529) looks decent, right now, so lets see what the trend of returns can tell us.

Understanding Return On Capital Employed (ROCE)

For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. To calculate this metric for Shandong Pharmaceutical GlassLtd, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.12 = CN¥916m ÷ (CN¥9.6b - CN¥1.8b) (Based on the trailing twelve months to March 2024).

Therefore, Shandong Pharmaceutical GlassLtd has an ROCE of 12%. On its own, that's a standard return, however it's much better than the 6.7% generated by the Medical Equipment industry.

View our latest analysis for Shandong Pharmaceutical GlassLtd

Above you can see how the current ROCE for Shandong Pharmaceutical GlassLtd compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for Shandong Pharmaceutical GlassLtd .

What The Trend Of ROCE Can Tell Us

While the current returns on capital are decent, they haven't changed much. The company has consistently earned 12% for the last five years, and the capital employed within the business has risen 113% in that time. 12% is a pretty standard return, and it provides some comfort knowing that Shandong Pharmaceutical GlassLtd has consistently earned this amount. Over long periods of time, returns like these might not be too exciting, but with consistency they can pay off in terms of share price returns.

The Bottom Line On Shandong Pharmaceutical GlassLtd's ROCE

In the end, Shandong Pharmaceutical GlassLtd has proven its ability to adequately reinvest capital at good rates of return. And the stock has followed suit returning a meaningful 56% to shareholders over the last five years. So while investors seem to be recognizing these promising trends, we still believe the stock deserves further research.

If you're still interested in Shandong Pharmaceutical GlassLtd it's worth checking out our FREE intrinsic value approximation for 600529 to see if it's trading at an attractive price in other respects.

If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.